about
Clinical guidelines on the management of hepatitis CThe clinical virology of hepatitis C virusSignificance of indeterminate third-generation hepatitis C virus recombinant immunoblot assayIndeterminate results of the second-generation hepatitis C virus (HCV) recombinant immunoblot assay: significance of high-level c22-3 reactivity and influence of HCV genotypesPrevalence and significance of hepatitis C virus (HCV) viremia in HCV antibody-positive subjects from various populationsSignificance of highly positive c22-3 "indeterminate" second-generation hepatitis C virus (HCV) recombinant immunoblot assay (RIBA) and resolution by third-generation HCV RIBAStorage conditions of blood samples and primer selection affect the yield of cDNA polymerase chain reaction products of hepatitis C virusPerformance of second- and third-generation RIBAs for confirmation of third-generation HCV EIA-reactive blood donations. Retrovirus Epidemiology Donor Study.Clinician's guide to diagnostic tests for hepatitis C virus infections.Infection with hepatitis C virus. New generation of assays should improve screening.Nucleotide sequences of the hepatitis C virus core region in patients without anti-core antibody.Idiopathic pulmonary fibrosis and hepatitis C virus infection.HCV antibodies in Hungarian blood donations. Experiences collected by ELISA tests, immunoblot assays and polymerase chain reaction and protocols for donor management.Also with a restrictive transfusion policy, screening with second-generation anti-hepatitis C virus enzyme-linked immunosorbent assay would have reduced post-transfusion hepatitis C after open-heart surgery.Hepatitis C virus confirmation in blood donor screening.The sexual transmission of hepatitis C virus.
P2860
Q27477946-520450A4-B470-4449-8C96-04AD72E7533AQ27481239-012217EE-EF8B-462B-B445-4CD930BF5BAEQ27485680-616C45A5-F9DD-4D7D-81D6-052C1F926DB3Q27485774-F47A8AB7-2601-4C3D-9072-A10A23FE2B58Q27487758-0DF4CF91-6D90-43B9-9A38-A2F3EBE2880EQ27487871-1F526BCA-7E2F-4B45-AA43-96FE5155B01BQ27488873-9554F836-B61E-4551-BAA7-DE1146ADC6C2Q34014697-BAEC339D-FAD6-49A0-A23A-A0190AFB18E6Q40141740-0A305A8A-067D-4A19-BDAF-353D37A47AE1Q42576945-5450E7B9-178F-4748-8F5E-61AED7A5D878Q42980888-91188889-B76F-4083-9E48-D4EAAD35B3F6Q43035239-C636725B-5827-404C-B152-B832A74A7F2BQ43036764-E30A2DC9-6C33-40EB-BE99-940778DAFEF2Q43039331-A01D2399-1315-4315-93E2-AA92CE66E181Q43048256-0F970BBE-296C-45B6-94A1-6EE937B9C066Q45786134-E6242107-52BF-455B-8F96-431BA39D9CB9
P2860
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
HCV confirmatory testing of blood donors.
@en
HCV confirmatory testing of blood donors.
@nl
type
label
HCV confirmatory testing of blood donors.
@en
HCV confirmatory testing of blood donors.
@nl
prefLabel
HCV confirmatory testing of blood donors.
@en
HCV confirmatory testing of blood donors.
@nl
P2093
P1433
P1476
HCV confirmatory testing of blood donors.
@en
P2093
E A Follett
P Simmonds
R Mitchell
P356
10.1016/0140-6736(91)91891-W
P407
P577
1991-10-01T00:00:00Z